Cargando…
Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer’s disease
BACKGROUND: Cognitive improvement has been reported in patients receiving centrally acting angiotensin-converting enzyme inhibitors (C-ACEIs). AIMS: To compare cognitive decline and survival after diagnosis of Alzheimer’s disease between people receiving C-ACEIs, non-centrally acting angiotensin-con...
Autores principales: | Fazal, Karim, Perera, Gayan, Khondoker, Mizanur, Howard, Robert, Stewart, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal College of Psychiatrists
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495996/ https://www.ncbi.nlm.nih.gov/pubmed/28713585 http://dx.doi.org/10.1192/bjpo.bp.116.004184 |
Ejemplares similares
-
Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia
por: Gao, Yang, et al.
Publicado: (2013) -
Factors Associated with Response to Acetylcholinesterase Inhibition in Dementia: A Cohort Study from a Secondary Mental Health Care Case Register in London
por: Perera, Gayan, et al.
Publicado: (2014) -
Trajectories of dementia-related cognitive decline in a large mental health records derived patient cohort
por: Baker, Elizabeth, et al.
Publicado: (2017) -
Borrowing strength from clinical trials in analysing longitudinal data from a treated cohort: investigating the effectiveness of acetylcholinesterase inhibitors in the management of dementia
por: Knight, Ruth, et al.
Publicado: (2022) -
Centrally Acting ACE Inhibitor Use and Physical Performance in Older Adults
por: George, C.J., et al.
Publicado: (2023)